Kyowa Kirin stops development of skin condition treatment [Yahoo! Finance]
KIRIN HLDGS CO LTD S/ADR (KNBWY)
US:NASDAQ Investor Relations:
kirinholdings.co.jp/english/ir
Company Research
Source: Yahoo! Finance
The drug, ?called rocatinlimab, is a monoclonal antibody that was being tested to treat skin conditions such as moderate-to-severe ?atopic dermatitis, ?prurigo nodularis, which cause dry, itchy, and inflamed skin. ?It was also tested for moderate-to-severe asthma. The decision was made after ?a recent ?planned safety ?update from the ?global rocatinlimab clinical program, Kyowa Kirin said. Based on this update, Kyowa Kirin and Amgen concluded that the potential risks may outweigh the benefits ?for patients. Earlier this ?year, Kyowa Kirin announced ?the termination ?of its development and ?commercialization collaboration for rocatinlimab ?with Amgen. Kyowa ?Kirin said it will control the global rocatinlimab program, including ?regulatory filings ?and future commercialization. (Reporting by Sneha ?S K in Bengaluru; Editing ?by Maju Samuel)
Show less
Read more
Impact Snapshot
Event Time:
KNBWY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KNBWY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KNBWY alerts
High impacting KIRIN HLDGS CO LTD S/ADR news events
Weekly update
A roundup of the hottest topics
KNBWY
News
- Kirin launches RTD brand Hyoketsu in US [Yahoo! Finance]Yahoo! Finance
- Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials [Yahoo! Finance]Yahoo! Finance
- Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands [Yahoo! Finance]Yahoo! Finance
- KIRIN HYOKETSU Expands into U.S. RTD Market with Local Production [Yahoo! Finance]Yahoo! Finance
- KIRIN HYOKETSU Expands into U.S. RTD Market with Local ProductionBusiness Wire